UK becomes first country to approve Pfizer-BioNTech Covid-19 vaccine for use

▴ UK becomes first country to approve Pfizer-BioNTech Covid-19 vaccine for use
Britain became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine today for use and said that it will be rolled out from early next week.

Britain became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine today for use and said that it will be rolled out from early next week.

The British regulator Medicines and Healthcare products Regulatory Agency (MHRA) declared that the vaccine offers protection of up to 95 percent and is safe to be used for immunization against Covid-19.
 

According to a media statement, the Government has accepted the recommendation from the Independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve the Pfizer-BioNTechs COVID-19 vaccine for use. The vaccine will be made available across the UK from next week.

 
The American pharmaceutical giant Pfizer and its German partner BioNTech last month concluded a phase 3 study of their mRNA-based Covid-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
 
The UK has ordered up to 40 million doses of the vaccine, which is being organized to vaccinate 20 million people with two shots each. Immunization is expected to start within days and will be delivered to high-priority groups first.

The company expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.

Tags : #Pfizer-BioNTech #Covid19Vaccine #MHRA #BioNTech #Pfizer #CovidVaccine #Vaccination #FightAgainstVirus #Britain #BritainGovernment #UnitedKingdom

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

University of Manchester invites applications for MSc Climate Change: Science, Society and Solutions December 13, 2024
Pollution vs. Population: Can India Survive Its Toxic Air?December 13, 2024
New Milestone: First Cryopreserved Stem Cell Donation Helps Blood Cancer Patient December 13, 2024
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in MacauDecember 13, 2024
Plastic Pollution Goes Personal: Microplastics Found in Human BloodDecember 12, 2024
The Fat-Fuelled Weapon Against Cancer: How the Keto Lifestyle is Redefining Cancer TherapyDecember 12, 2024
Gene Therapy in India: How Indian Scientists Redefined Hemophilia TreatmentDecember 12, 2024
Empowering India’s Workforce: FinX Raises $6M from Elevar Equity to revolutionise employability in the BFSI IndustryDecember 12, 2024
India’s Win Over Malaria: A Global Health Victory in ProgressDecember 11, 2024
TB-Free India by 2025: Bold Vision or Achievable Reality?December 11, 2024
Aakash Healthcare Supports the 14th Special Athletic Meet for Children with Special NeedsDecember 11, 2024
The University of Manchester invites applications for an MSc in International Disaster ManagementDecember 10, 2024
Preventing Mother-to-Child HIV Transmission: Strategies and ImportanceDecember 10, 2024
USIBC Signs MOU with Government of Telangana, Hosts AI and GCC Industry RoundtableDecember 10, 2024
CarDekho Group’s New Auto Segment’s Shift in Fuel Preferences Report: Electric Vehicles (EVs) Lead the Chart with 26% YoY Traffic Increase December 10, 2024
India’s leading eCommerce enablement platform Shiprocket appoints industry veteran Vivek Sharma as VP of International ShippingDecember 10, 2024
Failure to find all TB cases defeats us in #endTB effortsDecember 10, 2024
Fear of Missing Out or Fear of Missing Connections: How FOMO Reflects Our Need for BelongingDecember 10, 2024
Rewriting Elderly Care: Rs 5 Lakh Healthcare for India’s Elderly Through Ayushman Vay Vandana CardDecember 10, 2024
ISB DLabs in collaboration with CitiusTech launches ‘I-HEAL @ ISB 3.0’: Accelerating Digital Healthcare Innovation in IndiaDecember 10, 2024